Pictet Asset Management Holding Sa Gilead Sciences, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 4,261,363 shares of GILD stock, worth $395 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
4,261,363
Previous 2,581,509
65.07%
Holding current value
$395 Million
Previous $177 Million
101.67%
% of portfolio
0.41%
Previous 0.21%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
993MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.7 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.1 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.74 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.58 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $116B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...